APLS Competitors & Alternatives
Compare Apellis Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
APLS
Main Stock$41.03
Tradestie Score
50
Market Cap
$2.92B
P/E Ratio
38.3
Revenue Growth
0.6%
Analyst Upside
-0.2%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$20.41
|
$6.03B | - | 36 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.15
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$140.97
|
$5.92B | - | 60 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$64.26
|
$5.80B | 94.6 | 33 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$306.50
|
$5.20B | 41.2 | 51 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$66.36
|
$4.94B | - | 40 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$64.14
|
$4.93B | - | 41 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$49.00
|
$4.84B | - | 47 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More APLS Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry